Gyros Protein Technologies
Gyros Protein Technologies provides immunoassay and peptide synthesis solutions that enable scientists to increase their productivity in translational research and biotherapeutic development.
The automated Gyrolab® CD-based microfluidic immunoassay platform and expanding portfolio of kits are trusted by pharma, biotech, CRO and CMO companies worldwide to accelerate the development and manufacturing of biotherapies including cell and gene therapies. Gyrolab technology provides high-precision, low sample volume, and robust immunoassays in preclinical/clinical development and bioprocess applications including PK, immunogenicity, biomarkers and affinity.
Our best-in-class solid phase peptide synthesizers including Tribute®, Prelude® X, Symphony® X, Sonata® and PurePep® Chorus® are used in universities, biotechnology and pharmaceutical companies worldwide to deliver uncompromising purity, flexibility, and quality from discovery to preclinical studies.
Formed by the merger of Gyros AB founded in 2000, and Protein Technologies, Inc., founded in 1985, Gyros Protein Technologies is now part of Mesa Labs, a growing confederation of leading-edge brands dedicated to protecting critical environments, products and people.
Gyros Protein Technologies introduces Gyrolab AAVX Titer kit to support cell and gene therapy market
Gyros Protein Technologies introduces Gyrolab p24 kit to support the cell and gene therapy market
eBook: the use of automation in the bioanalytical lab
In the Zone: the use of singlicate analysis in LBAs
Gyrolab technology – a must-have in biotherapeutics development and manufacturing
Panel discussion: drug development, instrumentation and practical implications of COVID-19
Panel discussion: novel techniques and the new age of biomarkers
Panel discussion: the impact of new technologies
Panel discussion: considerations and challenges of ligand binding assays
Fast and convenient generic LBA for the detection of ADA in monkey plasma using Gyrolab® platform
Singlet analysis using Gyrolab® LBAs, a new normal in abnormal times
Generic PK methods for the quantification of mAbs using Gyrolab® and LC–MS/MS
Gyros Protein Technologies provides enabling peptide synthesis and bioanalytical solutions that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. Our low to mid-scale peptide synthesizer platforms are the new PurePep™ Chorus, Symphony® X, and PurePep® SONATA®. These solutions provide parallel synthesis and along with our chemistries deliver uncompromising purity, flexibility, and quality synthesis for discovery and pre-clinical studies of simple to complex multifunctional peptides. For bioanalysis, our proprietary high performance nanoliter-scale immunoassay platforms, Gyrolab® xPand, Gyrolab® xP workstation and Gyrolab xPlore™, and Gyrolab immunoassay kits, are used by scientists in leading pharmaceutical, biotech, CRO, and CMO companies in the development and manufacturing of various biotherapies including those based on peptides, antibodies, and gene therapies and vaccines. Gyrolab immunoassays provide key workflow advantages of speed, automation, and low reagent usage, and assay quality advantages of wide dynamic range with robust precision and reproducibility in applications including pharmacokinetics/pharmacodynamics, immunogenicity, and bioprocess titer and impurities. Our peptide synthesis and bioanalytical solutions accelerate the discovery, development, and manufacturing of safer biotherapeutics. Gyros Protein Technologies is a division of Mesa Laboratories.
Website: www.gyrosproteintechnologies.com/
Email: [email protected]
Address:
Uppsala Science Park
Dag Hammarskjölds väg 54
751 83 Uppsala, Sweden
+46 (0)18 56 63 00